JP2014525448A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014525448A5 JP2014525448A5 JP2014528537A JP2014528537A JP2014525448A5 JP 2014525448 A5 JP2014525448 A5 JP 2014525448A5 JP 2014528537 A JP2014528537 A JP 2014528537A JP 2014528537 A JP2014528537 A JP 2014528537A JP 2014525448 A5 JP2014525448 A5 JP 2014525448A5
- Authority
- JP
- Japan
- Prior art keywords
- imidazo
- oxadiazol
- pyridine
- methyl
- methylphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161530038P | 2011-09-01 | 2011-09-01 | |
| US61/530,038 | 2011-09-01 | ||
| PCT/US2012/052802 WO2013033167A1 (en) | 2011-09-01 | 2012-08-29 | Compounds and compositions as c-kit kinase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014525448A JP2014525448A (ja) | 2014-09-29 |
| JP2014525448A5 true JP2014525448A5 (enExample) | 2015-10-29 |
| JP6134319B2 JP6134319B2 (ja) | 2017-05-24 |
Family
ID=46829904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014528537A Active JP6134319B2 (ja) | 2011-09-01 | 2012-08-29 | ｃ−ｋｉｔキナーゼインヒビターとしての化合物及び組成物 |
Country Status (30)
| Country | Link |
|---|---|
| US (3) | US8569283B2 (enExample) |
| EP (1) | EP2751104B1 (enExample) |
| JP (1) | JP6134319B2 (enExample) |
| KR (1) | KR101962495B1 (enExample) |
| CN (1) | CN103797011B (enExample) |
| AP (1) | AP2014007493A0 (enExample) |
| AR (1) | AR087753A1 (enExample) |
| AU (1) | AU2012302042B2 (enExample) |
| BR (1) | BR112014004560A2 (enExample) |
| CA (1) | CA2845169C (enExample) |
| CL (1) | CL2014000492A1 (enExample) |
| CO (1) | CO6900141A2 (enExample) |
| CR (1) | CR20140107A (enExample) |
| CU (1) | CU20140024A7 (enExample) |
| EA (1) | EA026152B1 (enExample) |
| ES (1) | ES2761332T3 (enExample) |
| GT (1) | GT201400034A (enExample) |
| IL (1) | IL231227A0 (enExample) |
| MA (1) | MA35460B1 (enExample) |
| MX (1) | MX339937B (enExample) |
| PE (1) | PE20140909A1 (enExample) |
| PH (1) | PH12014500372A1 (enExample) |
| PL (1) | PL2751104T3 (enExample) |
| PT (1) | PT2751104T (enExample) |
| SG (1) | SG2014014369A (enExample) |
| TN (1) | TN2014000068A1 (enExample) |
| TW (1) | TW201313717A (enExample) |
| UY (1) | UY34301A (enExample) |
| WO (1) | WO2013033167A1 (enExample) |
| ZA (1) | ZA201401175B (enExample) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9199981B2 (en) * | 2011-09-01 | 2015-12-01 | Novartis Ag | Compounds and compositions as C-kit kinase inhibitors |
| AP2014007493A0 (en) | 2011-09-01 | 2014-03-31 | Irm Llc | Compounds and compositions as C-KIT kinase inhibitors |
| CN109568319A (zh) | 2013-01-10 | 2019-04-05 | 普尔莫凯恩股份有限公司 | 非选择性激酶抑制剂 |
| US9242969B2 (en) | 2013-03-14 | 2016-01-26 | Novartis Ag | Biaryl amide compounds as kinase inhibitors |
| WO2015054574A1 (en) | 2013-10-11 | 2015-04-16 | Zisman Lawrence S | Spray dry formulations |
| US20150288928A1 (en) * | 2014-04-08 | 2015-10-08 | Sony Corporation | Security camera system use of object location tracking data |
| CN105384738B (zh) * | 2014-08-21 | 2017-08-29 | 上海科州药物研发有限公司 | 作为蛋白激酶抑制剂的杂环类化合物及其制备方法和用途 |
| UY36294A (es) | 2014-09-12 | 2016-04-29 | Novartis Ag | Compuestos y composiciones como inhibidores de quinasa |
| KR102710552B1 (ko) | 2015-07-02 | 2024-09-25 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | 항균 화합물 |
| US10474987B2 (en) * | 2015-08-05 | 2019-11-12 | Whirlpool Corporation | Object recognition system for an appliance and method for managing household inventory of consumables |
| US20190256509A1 (en) * | 2016-06-08 | 2019-08-22 | Chrysalis, Inc. | Histone demethylase inhibitors |
| EP3472152A1 (en) | 2016-06-16 | 2019-04-24 | Janssen Sciences Ireland Unlimited Company | Heterocyclic compounds as antibacte rials |
| BR112018076126A2 (pt) | 2016-06-16 | 2019-03-26 | Janssen Sciences Ireland Unlimited Company | compostos heterocíclicos como antibacterianos |
| EP3515446B1 (en) | 2016-09-19 | 2023-12-20 | Novartis AG | Therapeutic combinations comprising a raf inhibitor and a erk inhibitor |
| EP3532063A4 (en) | 2016-10-27 | 2020-07-22 | Pulmokine, Inc. | POLYTHERAPY FOR THE TREATMENT OF PULMONARY HYPERTENSION |
| US20180162291A1 (en) * | 2016-12-12 | 2018-06-14 | Wipro Limited | System and method of dynamically adjusting field of view of an image capturing device |
| KR20240053077A (ko) | 2017-03-01 | 2024-04-23 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | 병용 요법 |
| WO2018203219A1 (en) | 2017-05-02 | 2018-11-08 | Novartis Ag | Combination therapy |
| US11939320B2 (en) | 2017-11-02 | 2024-03-26 | Abbvie Inc. | Modulators of the integrated stress pathway |
| KR102625224B1 (ko) * | 2018-10-31 | 2024-01-15 | 주식회사 큐로젠 | 피라졸-온 유도체를 유효성분으로 포함하는 자가면역질환의 예방, 개선 또는 치료용 조성물 |
| US20220143049A1 (en) | 2019-03-21 | 2022-05-12 | Onxeo | A dbait molecule in combination with kinase inhibitor for the treatment of cancer |
| AU2020274564A1 (en) * | 2019-05-13 | 2021-12-09 | Novartis Ag | Crystalline forms of N- (5- (5- ( (1R, 2S) -2-fluorocyclopropyl) -1, 2, 4-oxadiazol-3-yl) -2-methylphenyl) imidazo [1, 2-a] pyridine-3-carboxamide |
| US12187703B2 (en) | 2019-05-13 | 2025-01-07 | Novartis Ag | Crystalline forms of N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methvlphenyl)-2 (trifluoromethyl)isonicotinamide as Raf inhibitors for the treatment of cancer |
| WO2021035788A1 (zh) | 2019-08-29 | 2021-03-04 | 中国科学院合肥物质科学研究院 | 吡唑衍生物及其用途 |
| ES2978573T3 (es) | 2019-09-13 | 2024-09-16 | Janssen Sciences Ireland Unlimited Co | Compuestos antibacterianos |
| EP4054579A1 (en) | 2019-11-08 | 2022-09-14 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Methods for the treatment of cancers that have acquired resistance to kinase inhibitors |
| BR112022011017A2 (pt) | 2019-12-13 | 2022-08-16 | Nippon Shinyaku Co Ltd | Composto que funciona como inibidor de receptor quinase de pdgf, e composição |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
| EP4181921A4 (en) | 2020-07-15 | 2025-02-26 | Third Harmonic Bio, Inc. | CRYSTALLINE FORMS OF A SELECTIVE C-KIT KINASE INHIBITOR |
| TW202237097A (zh) | 2020-11-19 | 2022-10-01 | 美商第三諧波生物公司 | 選擇性ｃ－ｋｉｔ激酶抑制劑之醫藥組合物及其製造及使用方法 |
| EP4308239A1 (en) | 2021-03-16 | 2024-01-24 | Janssen Sciences Ireland Unlimited Company | Antibacterial compounds |
| CA3212074A1 (en) | 2021-03-17 | 2022-09-22 | Janssen Sciences Ireland Unlimited Company | Antibacterial compounds |
| WO2022194905A1 (en) | 2021-03-17 | 2022-09-22 | Janssen Sciences Ireland Unlimited Company | Antibacterial compounds |
| IL312366A (en) | 2021-10-28 | 2024-06-01 | Janssen Sciences Ireland Unlimited Co | Imidazopyridine amides and related compounds for use in the treatment of bacterial infections |
| WO2024089170A1 (en) | 2022-10-27 | 2024-05-02 | Janssen Sciences Ireland Unlimited Company | Antibacterial compounds |
| EP4626884A1 (en) * | 2022-11-30 | 2025-10-08 | Blueprint Medicines Corporation | N-phenyl-pyrazolo[1,5-a]pyridine-3-carboxamide derivatives as wild type c-kit kinase inhibitors for the treatment of urticaria |
| AU2023390239A1 (en) * | 2022-12-07 | 2025-07-24 | Third Harmonic Bio, Inc. | Compounds and compositions as c-kit kinase inhibitors |
| JP2025541191A (ja) * | 2022-12-07 | 2025-12-18 | サード ハーモニック バイオ， インコーポレイテッド | Ｃ－ｋｉｔキナーゼ阻害剤としての化合物及び組成物 |
| WO2024223859A1 (en) | 2023-04-26 | 2024-10-31 | Janssen Pharmaceutica Nv | Antibacterial compounds |
| WO2025072330A1 (en) * | 2023-09-26 | 2025-04-03 | Arcus Biosciences, Inc. | Kit inhibitor compounds and methods of use thereof |
| WO2025256552A1 (zh) * | 2024-06-11 | 2025-12-18 | 上海翰森生物医药科技有限公司 | 吡唑类衍生物抑制剂、其制备方法和应用 |
| WO2025256609A1 (en) * | 2024-06-13 | 2025-12-18 | Third Harmonic Bio, Inc. | Crystalline forms of a selective c-kit kinase inhibitor |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004078163A2 (en) | 2003-02-28 | 2004-09-16 | Transform Pharmaceuticals, Inc. | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| WO2004001903A2 (en) | 2002-06-20 | 2003-12-31 | Beacon Looms, Inc. | Knitted electrical conductor fabric |
| CA2591321C (en) | 2004-09-09 | 2013-09-24 | Natco Pharma Limited | Phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase |
| EP2942349A1 (en) | 2004-12-23 | 2015-11-11 | Deciphera Pharmaceuticals, LLC | Enzyme modulators and treatments |
| US7754717B2 (en) | 2005-08-15 | 2010-07-13 | Amgen Inc. | Bis-aryl amide compounds and methods of use |
| JP2010509349A (ja) * | 2006-11-03 | 2010-03-25 | アイアールエム・リミテッド・ライアビリティ・カンパニー | タンパク質キナーゼ阻害剤としての化合物および組成物 |
| JP6117104B2 (ja) * | 2010-11-15 | 2017-04-19 | アッヴィ・インコーポレイテッド | Ｎａｍｐｔおよびｒｏｃｋ阻害薬 |
| US20130023751A1 (en) | 2011-07-18 | 2013-01-24 | Samuel Victor Lichtenstein | Water retention monitoring |
| WO2013033203A1 (en) | 2011-09-01 | 2013-03-07 | Irm Llc | Compounds and compositions as c-kit kinase inhibitors |
| WO2013033620A1 (en) | 2011-09-01 | 2013-03-07 | Irm Llc | Compounds and compositions as pdgfr kinase inhibitors |
| US9199981B2 (en) | 2011-09-01 | 2015-12-01 | Novartis Ag | Compounds and compositions as C-kit kinase inhibitors |
| AP2014007493A0 (en) | 2011-09-01 | 2014-03-31 | Irm Llc | Compounds and compositions as C-KIT kinase inhibitors |
-
2012
- 2012-08-29 AP AP2014007493A patent/AP2014007493A0/xx unknown
- 2012-08-29 SG SG2014014369A patent/SG2014014369A/en unknown
- 2012-08-29 PE PE2014000295A patent/PE20140909A1/es not_active Application Discontinuation
- 2012-08-29 EA EA201490545A patent/EA026152B1/ru not_active IP Right Cessation
- 2012-08-29 EP EP12756885.5A patent/EP2751104B1/en active Active
- 2012-08-29 CA CA2845169A patent/CA2845169C/en active Active
- 2012-08-29 PL PL12756885T patent/PL2751104T3/pl unknown
- 2012-08-29 CN CN201280042743.4A patent/CN103797011B/zh active Active
- 2012-08-29 PT PT127568855T patent/PT2751104T/pt unknown
- 2012-08-29 JP JP2014528537A patent/JP6134319B2/ja active Active
- 2012-08-29 AU AU2012302042A patent/AU2012302042B2/en not_active Ceased
- 2012-08-29 ES ES12756885T patent/ES2761332T3/es active Active
- 2012-08-29 PH PH1/2014/500372A patent/PH12014500372A1/en unknown
- 2012-08-29 WO PCT/US2012/052802 patent/WO2013033167A1/en not_active Ceased
- 2012-08-29 KR KR1020147008107A patent/KR101962495B1/ko active Active
- 2012-08-29 MX MX2014002484A patent/MX339937B/es active IP Right Grant
- 2012-08-29 UY UY34301A patent/UY34301A/es not_active Application Discontinuation
- 2012-08-29 BR BR112014004560A patent/BR112014004560A2/pt not_active Application Discontinuation
- 2012-08-29 US US13/598,213 patent/US8569283B2/en active Active
- 2012-08-31 TW TW101131942A patent/TW201313717A/zh unknown
- 2012-08-31 AR ARP120103223 patent/AR087753A1/es unknown
-
2013
- 2013-09-19 US US14/031,792 patent/US8754071B2/en active Active
-
2014
- 2014-02-17 TN TNP2014000068A patent/TN2014000068A1/en unknown
- 2014-02-17 ZA ZA2014/01175A patent/ZA201401175B/en unknown
- 2014-02-27 GT GT201400034A patent/GT201400034A/es unknown
- 2014-02-27 CL CL2014000492A patent/CL2014000492A1/es unknown
- 2014-02-27 IL IL231227A patent/IL231227A0/en unknown
- 2014-02-27 CU CU20140024A patent/CU20140024A7/es unknown
- 2014-02-28 CO CO14043417A patent/CO6900141A2/es unknown
- 2014-02-28 CR CR20140107A patent/CR20140107A/es unknown
- 2014-03-28 MA MA36864A patent/MA35460B1/fr unknown
- 2014-04-22 US US14/258,963 patent/US9023839B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014525448A5 (enExample) | ||
| ES2727376T3 (es) | Derivados de aminotriazina útiles como compuestos inhibidores de quinasa de unión TANK | |
| JP2019530667A (ja) | ピリジル置換のインドール化合物 | |
| CN113544130A (zh) | 一种btk抑制剂环衍生物及其制备方法和药学上的应用 | |
| JP2019530667A5 (enExample) | ||
| JP2015522002A5 (enExample) | ||
| JP2024521618A (ja) | 複素環式化合物 | |
| AU2008267894A1 (en) | Isoxazole-imidazole derivatives | |
| RU2015144485A (ru) | Геминально-замещенные цианоэтилпиразолопиридоны в качестве ингибиторов janus киназ | |
| JP2023523300A (ja) | Ｃｃｒ６受容体調節剤としてのアゼチジン－３－イルメタノール誘導体 | |
| IL279266B2 (en) | New isoxazolyl ether derivatives as gaba a alpha5 pam | |
| WO2022165530A1 (en) | Small molecule inhibitors of salt inducible kinases | |
| TW202233598A (zh) | PPARγ調節劑及使用方法 | |
| AU2023250382A1 (en) | Egfr inhibitors | |
| WO2021228795A1 (en) | New triazolyl derivatives as gaba a alpha5 pam | |
| EA049700B1 (ru) | Производные азетидин-3-илметанола в качестве модуляторов рецептора ccr6 | |
| HK1233645A1 (en) | Aminotriazine derivatives useful as tank-binding kinase inhibitor compounds |